VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

8302	Companies
115125	Keywords
55448	Articles
62531	Press releases

Home
Companies
VALBIOTIS

BRIEF

published on 06/04/2024 at 08:05, 5 months 17 days ago

Valbiotis and Nestlé Health Science terminate their licensing agreement

Diabetes Valbiotis Intellectual Property Dietary Supplement Nestlé Health Science
PRESS RELEASE

published on 06/04/2024 at 08:00, 5 months 17 days ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis terminates licensing and supply agreement with Nestlé Health Science, securing full ownership of TOTUM•63 for diabetes treatment. Strategic control and future partnerships planned

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF

published on 05/24/2024 at 17:45, 5 months 28 days ago

VALBIOTIS: Monthly information on voting rights and shares as of May 17, 2024

Share Capital Voting Rights Euronext Actions Valbiotis
BRIEF

published on 05/22/2024 at 17:45, 5 months 30 days ago

Valbiotis launches its e-commerce site for Valbiotis®PRO Cholesterol

E-commerce Valbiotis Lipidrive Hypercholesterolemia Food Supplements
PRESS RELEASE

published on 05/22/2024 at 17:40, 5 months 30 days ago

Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol
Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol on schedule, making innovative products accessible to all, including the Valbiotis®PLUS range of natural dietary supplements

Digital Marketing Valbiotis Dietary Supplements Valbiotis®PRO Cholestérol E-commerce Site
BRIEF

published on 05/14/2024 at 08:35, 6 months 7 days ago

Valbiotis publishes its voting rights figures for April 2024

Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF

published on 05/14/2024 at 08:35, 6 months 7 days ago

Valbiotis announces its latest capital and voting rights indicators

Euronext Growth Paris Share Capital Voting Rights Actions Valbiotis
BRIEF

published on 04/26/2024 at 07:35, 6 months 25 days ago

Valbiotis announces its financial results and strategic progress for 2023

Valbiotis Financial Results 2023 Metabolic Disorders TOTUM•63 Food Supplements
PRESS RELEASE

published on 04/26/2024 at 07:30, 6 months 25 days ago

Valbiotis publishes its annual accounts 2023
Valbiotis publishes annual accounts 2023 with solid cash position of over €25 million. Highlights include successful TOTUM•63 study and upcoming market launches

Cash Position Valbiotis Annual Accounts TOTUM•63 Market Launches
BRIEF

published on 04/08/2024 at 17:45, 7 months 13 days ago

Valbiotis announces its number of voting rights and shares for March 2024

Euronext Growth Paris Share Capital Voting Rights Transparency Valbiotis

Accesswire

Published on 11/22/2024 at 00:00, 12 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 2 hours 7 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 22 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 57 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 4 hours 2 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 5 hours 11 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 36 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 14 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 20 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 21 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 17 hours 14 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE